Skip to main content

Table 2 Receptor status, subtypes and clinical pathological features

From: Triple negative breast cancer in a poor resource setting in North-Western Tanzania: a preliminary study of 52 patients

   Cancer subtype    
Lumina A Lumina B HER2 enriched TN p-value
Variable n (%) n (%) n (%) n (%)  
Age below 50 years 11(61.1) 6(66.6) 1(20) 9(45) 0.282
Lymph node involvement 11 (61.1) 7(77.7) 4(80) 16(80) 0.568
Ki-67 high labelling 17(80.9) 4(44.4) 1(50) 17(85) 0.128
Tumour size above 6 cm 6(33.3) 7 (77.7) 5(100) 13(65) 0.009*